On Sep 22, 2021 Oxford BioMedica closed a Post-IPO Equity round and raised £50,000,000 from Serum Institute of India Pvt. Ltd., featuring lead investors Serum […]
Series B – Hexagon Bio
On Sep 22, 2021 Hexagon Bio closed a Series B round and raised $61,000,001 from 8VC, Casdin Capital, Nextech Invest, SoftBank Vision Fund, The Column […]
Series B – Hexagon Bio
On Sep 22, 2021 Hexagon Bio closed a Series B round and raised $61,000,001 from 8VC, Casdin Capital, Nextech Invest, SoftBank Vision Fund, The Column […]
Series B – SmartLabs
On Sep 20, 2021 SmartLabs closed a Series B round and raised $250,000,000 from ArrowMark Partners, Breed’s Hill Capital, Conversion Ventures LLC, Onex Falcon, Winslow […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Grant – Pegasus Biotech
On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Avitide acquired by Repligen
Sep 16, 2021 Repligen has entered into an agreement to acquire Avitide in a $150,000,000 deal. Repligen based at Waltham, Massachusetts, United States. “Repligen: Inspiring […]
Grant – Rhaeos
On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – Othram
On Sep 16, 2021 Othram closed a Series B round and raised $18,000,000 from Gigafund, featuring lead investors Gigafund. About the company: Othram is located […]
